Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, September 2000, p. 781-787, Vol. 7, No. 5
Department of Immunology and Infectious
Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto,
California 94301,1 and Division of
Infectious Diseases and Geographic Medicine, Department of
Medicine, Stanford University School of Medicine, Stanford, California
943052
Received 10 March 2000/Returned for modification 8 May
2000/Accepted 14 June 2000
An enzyme-linked immunosorbent assay (ELISA) using four recombinant
antigens of Toxoplasma gondii (rP22, rP25, rP29, and rP35) was used in an attempt to differentiate pregnant women with toxoplasma serologic profiles (TSPs) indicative of recently acquired infections (acute profile) from those with TSPs indicative of infections acquired
in the distant past (chronic profile). In general, immunoglobulin G
antibodies in sera from women with the acute profile reacted more
strongly with the recombinant antigens than did those in sera from
women with the chronic profile. However, reactivities differed
significantly between antigens that reacted with a single serum and
between sera that reacted with a single antigen. Because of these
variations, we employed a combination of the four antigens in an ELISA
(Comb-ELISA) and evaluated its ability to distinguish pregnant women
with the acute profile from those with the chronic profile. Eighteen of
20 (90%) sera from acute-profile women were positive in the
Comb-ELISA, whereas 69 of 70 (98.6%) sera from the chronic-profile
women were negative. Thus, the Comb-ELISA may be useful for diagnosis
of toxoplasmosis in pregnant women and for differentiation between
recently acquired infections and infections acquired in the more
distant past.
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Serodiagnosis of Recently Acquired Toxoplasma
gondii Infection Using an Enzyme-Linked Immunosorbent Assay with a
Combination of Recombinant Antigens
*
Corresponding author. Mailing address: Research
Institute, Palo Alto Medical Foundation, 795 El Camino Real, Palo Alto,
CA 94301. Phone: (650) 326-8120. Fax: (650) 329-9853.
Present address: Maxygen, Redwood City, CA 94063.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»